Heart Clinical Trials

At Genesis Heart Institute, you may get an opportunity to enroll in a clinical trial that tests the safety and effectiveness of a new cardiovascular therapy. In the Quad Cities, you’ll find this option at the Heart Institute because we emphasize innovation so we can better help patients. If you’re interested in a clinical trial, ask your doctor about whether it’s right for you. We’ll help you explore all your treatment possibilities.

Participating in Clinical Trials

To help determine whether you’re eligible for a certain clinical trial, a health care professional will review your medical history. You also may need to receive health screenings, including blood and urine analysis. Your age, sex, previous treatments, type and stage of disease, and other health conditions could affect your eligibility.

If you qualify for a clinical trial, you can choose whether to take part. By enrolling, you’ll gain access to a promising treatment that’s not widely available, and you’ll contribute to medical research that may benefit other patients. But it’s important to remember that your condition may or may not improve during the study. And, like established therapies, new drugs or procedures may cause side effects.

Talk to your physician to make sure you fully understand what the clinical trial would involve. Even if you decide to take part, you may leave the study at any time.

Current Heart & Vascular Clinical Trials

Find cardiovascular clinical trials at Genesis that are now enrolling participants. Learn more about the Genesis Research Program here.

Showing 1-6 of 6

Sorted By:

  • Adherent Sleep Apnea Patients

    The purpose of this study is to categorize sleep apnea patients based on their reason for sleep study referral and their level of adherence, and examine whether this categorization has an effect on key health outcomes.

  • CardioMEMS

    The purpose of this study is to show that data collected about the use of the CardioMEMS HF System in patient care are similar with data collected in a controlled clinical study. This study will be done at up to 150 clinical sites in the United States (US). There will be 1,200 patients included in the study.

  • MIMICS-2 Study

    The purpose of this study is to evaluate a new stent which may be used in patients that have a blockage in one or more blood vessels (arteries) in the leg.

  • PALM Registry

    The purpose of this registry is to learn more about how doctors prescribe cholesterol lowering medications using the current and previous health guidelines. The study also wants to learn about barriers to disease prevention and knowledge of treatment goals among patients using cholesterol lowering medications and those that do not. The investigators hope the information gained will help to understand doctors’ treatment patterns, introduce new treatments and make current treatment guidelines clearer for cholesterol lowering therapies.

  • Psychology Research: Impact of Therapy Dogs

    The purpose of this study is to see if therapy dogs can help family members of surgical or cardiac patients feel less worried or stressed.

  • SAFE-DCB U.S. Registry

    The purpose of this patient registry is to assess the safety and usage of the Lutonix® DCB PTA catheter.

Showing trials 1-6 of 6

Contact Us

Your Question Deserves an Answer

We are here to answer your questions and address your concerns. Fill out our quick "contact us" form or call 563-421-3900 and we'll get back to you ASAP.


Starting Again with TAVR

Bonnie Morris, TAVR patient

Bonnie Morris knows what it means to have surgery: she's had her left lung removed, heart bypass surgery and the placement of a pacemaker. But after being diagnosed with severe aortic stenosis, Mrs. Morris didn't find relief through a complex, open-chest surgery--she had TAVR.

Read Her Story

Related Locations